| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 113 | 2024 | 3079 | 7.670 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 33 | 2024 | 518 | 6.930 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 47 | 2019 | 835 | 6.000 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 20 | 2024 | 236 | 3.810 |
Why?
|
| Interleukin-9 | 8 | 2018 | 63 | 1.800 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 2 | 2021 | 150 | 1.230 |
Why?
|
| Immunologic Factors | 10 | 2023 | 1580 | 1.230 |
Why?
|
| Immunosuppressive Agents | 18 | 2023 | 4149 | 1.170 |
Why?
|
| Lymphocyte Activation | 30 | 2016 | 5524 | 1.150 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 9 | 2019 | 986 | 1.100 |
Why?
|
| Th17 Cells | 6 | 2017 | 766 | 1.040 |
Why?
|
| Microglia | 8 | 2021 | 1266 | 1.030 |
Why?
|
| T-Lymphocytes | 36 | 2011 | 10180 | 0.920 |
Why?
|
| Immunoconjugates | 9 | 2008 | 901 | 0.890 |
Why?
|
| Cytokines | 29 | 2017 | 7322 | 0.870 |
Why?
|
| Vitamin D Deficiency | 3 | 2017 | 1343 | 0.860 |
Why?
|
| Interferon-gamma | 31 | 2018 | 3206 | 0.850 |
Why?
|
| T-Lymphocyte Subsets | 13 | 2018 | 1838 | 0.830 |
Why?
|
| Cholecalciferol | 2 | 2017 | 537 | 0.830 |
Why?
|
| Interleukin-17 | 8 | 2018 | 899 | 0.820 |
Why?
|
| Th1 Cells | 15 | 2005 | 1057 | 0.790 |
Why?
|
| Dendritic Cells | 8 | 2014 | 2725 | 0.780 |
Why?
|
| Demyelinating Diseases | 8 | 2023 | 354 | 0.780 |
Why?
|
| Immune Tolerance | 24 | 2012 | 2258 | 0.740 |
Why?
|
| Cell Differentiation | 19 | 2018 | 11483 | 0.730 |
Why?
|
| Viral Matrix Proteins | 1 | 2021 | 186 | 0.730 |
Why?
|
| Albuterol | 3 | 2010 | 208 | 0.720 |
Why?
|
| Neural Stem Cells | 3 | 2019 | 851 | 0.710 |
Why?
|
| Autoimmunity | 11 | 2017 | 1349 | 0.710 |
Why?
|
| Monocytes | 11 | 2013 | 2596 | 0.690 |
Why?
|
| Disease Progression | 26 | 2023 | 13284 | 0.680 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2019 | 53 | 0.680 |
Why?
|
| T-Lymphocytes, Regulatory | 8 | 2019 | 2988 | 0.660 |
Why?
|
| CD4-Positive T-Lymphocytes | 17 | 2017 | 4386 | 0.660 |
Why?
|
| Calcifediol | 2 | 2017 | 166 | 0.650 |
Why?
|
| Antigens, Ly | 2 | 2011 | 291 | 0.650 |
Why?
|
| Nervous System Diseases | 4 | 2019 | 1622 | 0.640 |
Why?
|
| Stem Cells | 10 | 2008 | 3567 | 0.640 |
Why?
|
| Central Nervous System | 10 | 2016 | 1357 | 0.640 |
Why?
|
| Th2 Cells | 14 | 2008 | 1061 | 0.630 |
Why?
|
| Toluidines | 1 | 2017 | 19 | 0.610 |
Why?
|
| Crotonates | 1 | 2017 | 19 | 0.610 |
Why?
|
| Water Pollution | 1 | 2016 | 32 | 0.580 |
Why?
|
| Oligodendroglia | 2 | 2019 | 517 | 0.580 |
Why?
|
| Interleukin-4 | 8 | 2013 | 1147 | 0.580 |
Why?
|
| Antigen-Presenting Cells | 9 | 2009 | 973 | 0.570 |
Why?
|
| Water Purification | 1 | 2016 | 48 | 0.560 |
Why?
|
| Membrane Glycoproteins | 13 | 2007 | 3768 | 0.560 |
Why?
|
| Exosomes | 1 | 2021 | 417 | 0.560 |
Why?
|
| Lectins | 1 | 2019 | 513 | 0.560 |
Why?
|
| Smad3 Protein | 2 | 2017 | 180 | 0.550 |
Why?
|
| Cognition Disorders | 4 | 2021 | 4043 | 0.550 |
Why?
|
| Propylene Glycols | 2 | 2015 | 92 | 0.540 |
Why?
|
| Antigens, Differentiation | 9 | 2003 | 927 | 0.540 |
Why?
|
| Animals | 108 | 2021 | 168757 | 0.520 |
Why?
|
| Flow Cytometry | 13 | 2021 | 5974 | 0.520 |
Why?
|
| Mice | 63 | 2021 | 81183 | 0.510 |
Why?
|
| Magnetic Resonance Imaging | 42 | 2023 | 35421 | 0.510 |
Why?
|
| Thymus Gland | 6 | 1999 | 1267 | 0.510 |
Why?
|
| Lebanon | 11 | 2023 | 229 | 0.510 |
Why?
|
| Disabled Persons | 3 | 2023 | 1212 | 0.500 |
Why?
|
| Gadolinium | 5 | 2023 | 952 | 0.500 |
Why?
|
| Mice, Inbred C57BL | 33 | 2021 | 21827 | 0.500 |
Why?
|
| Nerve Degeneration | 4 | 2007 | 748 | 0.500 |
Why?
|
| Peptides | 13 | 2013 | 4409 | 0.490 |
Why?
|
| Calcitriol | 1 | 2016 | 298 | 0.490 |
Why?
|
| Interferon-beta | 8 | 2016 | 323 | 0.490 |
Why?
|
| Vitamins | 3 | 2017 | 1622 | 0.480 |
Why?
|
| Brain | 40 | 2023 | 26385 | 0.480 |
Why?
|
| Herpes Zoster | 1 | 2016 | 264 | 0.470 |
Why?
|
| Signal Transduction | 20 | 2019 | 23403 | 0.470 |
Why?
|
| Sphingosine | 2 | 2015 | 307 | 0.460 |
Why?
|
| Humans | 203 | 2024 | 744343 | 0.450 |
Why?
|
| Disability Evaluation | 10 | 2016 | 1827 | 0.450 |
Why?
|
| Adrenergic beta-Agonists | 3 | 2010 | 346 | 0.440 |
Why?
|
| Autoimmune Diseases | 12 | 2013 | 2133 | 0.440 |
Why?
|
| Female | 134 | 2024 | 380194 | 0.440 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2013 | 142 | 0.440 |
Why?
|
| Adjuvants, Immunologic | 7 | 2010 | 1000 | 0.440 |
Why?
|
| Myelin Proteins | 9 | 2012 | 215 | 0.440 |
Why?
|
| Interleukin-12 | 7 | 2006 | 579 | 0.440 |
Why?
|
| Nerve Regeneration | 5 | 2015 | 788 | 0.430 |
Why?
|
| Antigens, CD | 13 | 2009 | 4026 | 0.420 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2017 | 632 | 0.420 |
Why?
|
| Neurons | 11 | 2008 | 9338 | 0.420 |
Why?
|
| Osteopontin | 1 | 2013 | 296 | 0.410 |
Why?
|
| Receptor, Notch2 | 1 | 2012 | 89 | 0.410 |
Why?
|
| Capsid Proteins | 1 | 2015 | 479 | 0.400 |
Why?
|
| Severity of Illness Index | 15 | 2023 | 15540 | 0.400 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2012 | 67 | 0.390 |
Why?
|
| Adult | 89 | 2024 | 214055 | 0.380 |
Why?
|
| Antigens, Surface | 6 | 2010 | 1663 | 0.380 |
Why?
|
| Vitamin D | 3 | 2020 | 3223 | 0.380 |
Why?
|
| Exercise Test | 1 | 2018 | 2074 | 0.380 |
Why?
|
| Forkhead Transcription Factors | 4 | 2016 | 1613 | 0.380 |
Why?
|
| Lymphocytes | 5 | 2015 | 2617 | 0.370 |
Why?
|
| Tretinoin | 1 | 2013 | 517 | 0.370 |
Why?
|
| Neuropsychological Tests | 7 | 2021 | 6993 | 0.370 |
Why?
|
| Retina | 2 | 2022 | 2616 | 0.360 |
Why?
|
| Herpesvirus 4, Human | 1 | 2015 | 1041 | 0.350 |
Why?
|
| Cell Migration Inhibition | 1 | 2009 | 96 | 0.350 |
Why?
|
| Myelin-Associated Glycoprotein | 6 | 2009 | 113 | 0.340 |
Why?
|
| Refugees | 1 | 2016 | 511 | 0.340 |
Why?
|
| Mice, Inbred BALB C | 12 | 2012 | 6386 | 0.340 |
Why?
|
| Cells, Cultured | 24 | 2016 | 19229 | 0.340 |
Why?
|
| Receptor, Notch1 | 1 | 2012 | 502 | 0.330 |
Why?
|
| Male | 108 | 2023 | 350118 | 0.330 |
Why?
|
| Middle East | 7 | 2019 | 219 | 0.330 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2011 | 247 | 0.330 |
Why?
|
| Immunologic Surveillance | 1 | 2009 | 93 | 0.330 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2011 | 957 | 0.310 |
Why?
|
| Recurrence | 16 | 2024 | 8340 | 0.310 |
Why?
|
| Cognition | 5 | 2021 | 6770 | 0.310 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2007 | 1676 | 0.310 |
Why?
|
| Stem Cell Niche | 1 | 2011 | 346 | 0.300 |
Why?
|
| Meninges | 1 | 2009 | 190 | 0.300 |
Why?
|
| Macrophages | 3 | 2021 | 5655 | 0.300 |
Why?
|
| Scleroderma, Systemic | 1 | 2011 | 323 | 0.300 |
Why?
|
| Trans-Activators | 4 | 2008 | 2924 | 0.290 |
Why?
|
| Membrane Proteins | 6 | 2012 | 7880 | 0.290 |
Why?
|
| Transforming Growth Factor beta | 9 | 2012 | 2007 | 0.290 |
Why?
|
| Apoptosis | 7 | 2010 | 9727 | 0.290 |
Why?
|
| Cerebral Cortex | 6 | 2010 | 5708 | 0.290 |
Why?
|
| Middle Aged | 68 | 2023 | 213383 | 0.290 |
Why?
|
| Calcium-Binding Proteins | 2 | 2011 | 1081 | 0.290 |
Why?
|
| Spinal Cord | 7 | 2010 | 1809 | 0.280 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2011 | 2915 | 0.270 |
Why?
|
| Antigen Presentation | 6 | 2016 | 1284 | 0.270 |
Why?
|
| Cell Movement | 11 | 2015 | 5217 | 0.260 |
Why?
|
| CD40 Ligand | 8 | 2002 | 526 | 0.260 |
Why?
|
| Microscopy | 1 | 2011 | 903 | 0.260 |
Why?
|
| Antibodies, Monoclonal | 6 | 2016 | 9274 | 0.260 |
Why?
|
| Nervous System | 2 | 2006 | 554 | 0.260 |
Why?
|
| Immunoglobulin G | 5 | 2012 | 4560 | 0.260 |
Why?
|
| Axons | 2 | 2011 | 1684 | 0.260 |
Why?
|
| Models, Immunological | 1 | 2007 | 527 | 0.250 |
Why?
|
| Microscopy, Confocal | 5 | 2010 | 1970 | 0.250 |
Why?
|
| Rats, Inbred Lew | 15 | 2001 | 1162 | 0.250 |
Why?
|
| Young Adult | 20 | 2020 | 56430 | 0.250 |
Why?
|
| Immunologic Memory | 3 | 2015 | 1348 | 0.250 |
Why?
|
| Oncogene Proteins | 1 | 2008 | 749 | 0.240 |
Why?
|
| Adoptive Transfer | 7 | 2016 | 844 | 0.240 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 2 | 2015 | 121 | 0.230 |
Why?
|
| Overweight | 1 | 2015 | 2371 | 0.230 |
Why?
|
| Hedgehog Proteins | 1 | 2008 | 783 | 0.230 |
Why?
|
| Neuroglia | 4 | 2009 | 927 | 0.230 |
Why?
|
| Ovalbumin | 6 | 2004 | 719 | 0.230 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2005 | 369 | 0.230 |
Why?
|
| Autoantigens | 9 | 2012 | 892 | 0.230 |
Why?
|
| Stem Cell Transplantation | 3 | 2007 | 1620 | 0.230 |
Why?
|
| Corpus Callosum | 1 | 2007 | 737 | 0.220 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 8 | 2013 | 3870 | 0.220 |
Why?
|
| Mice, Transgenic | 11 | 2011 | 9734 | 0.220 |
Why?
|
| Inflammation | 6 | 2009 | 10638 | 0.210 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 2765 | 0.210 |
Why?
|
| Neural Crest | 1 | 2004 | 275 | 0.210 |
Why?
|
| Cyclophosphamide | 6 | 2004 | 2242 | 0.210 |
Why?
|
| Multipotent Stem Cells | 1 | 2003 | 186 | 0.210 |
Why?
|
| Cerebellar Nuclei | 2 | 2019 | 52 | 0.210 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2009 | 4479 | 0.210 |
Why?
|
| Blood Proteins | 3 | 2023 | 1124 | 0.210 |
Why?
|
| Atrophy | 7 | 2012 | 1583 | 0.210 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 1708 | 0.210 |
Why?
|
| Spleen | 8 | 2010 | 2362 | 0.200 |
Why?
|
| Interleukin-2 | 8 | 2014 | 1904 | 0.200 |
Why?
|
| Research | 3 | 2019 | 1999 | 0.200 |
Why?
|
| Meglumine | 2 | 2019 | 149 | 0.200 |
Why?
|
| Inflammation Mediators | 4 | 2010 | 1889 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2016 | 4751 | 0.200 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2002 | 104 | 0.190 |
Why?
|
| Arabs | 2 | 2020 | 178 | 0.190 |
Why?
|
| Cell Proliferation | 11 | 2019 | 10481 | 0.190 |
Why?
|
| Administration, Oral | 16 | 2015 | 3913 | 0.190 |
Why?
|
| Antigens | 6 | 1999 | 1466 | 0.190 |
Why?
|
| Malformations of Cortical Development | 1 | 2023 | 200 | 0.180 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2001 | 595 | 0.180 |
Why?
|
| Immune System Diseases | 1 | 2003 | 262 | 0.180 |
Why?
|
| Smoking | 2 | 2015 | 8987 | 0.180 |
Why?
|
| Neuromuscular Diseases | 1 | 2003 | 248 | 0.180 |
Why?
|
| Transplantation Tolerance | 2 | 2002 | 617 | 0.180 |
Why?
|
| Receptors, CXCR4 | 1 | 2004 | 726 | 0.180 |
Why?
|
| Disease Models, Animal | 11 | 2021 | 18029 | 0.180 |
Why?
|
| Bromodeoxyuridine | 2 | 2011 | 322 | 0.180 |
Why?
|
| STAT3 Transcription Factor | 2 | 2017 | 873 | 0.180 |
Why?
|
| Cell Separation | 4 | 2011 | 1751 | 0.170 |
Why?
|
| Maze Learning | 1 | 2021 | 478 | 0.170 |
Why?
|
| Interleukin-10 | 4 | 2016 | 1200 | 0.170 |
Why?
|
| Mice, Knockout | 11 | 2016 | 14557 | 0.170 |
Why?
|
| Hexosaminidases | 1 | 2019 | 54 | 0.170 |
Why?
|
| Prostatic Hyperplasia | 2 | 1994 | 523 | 0.170 |
Why?
|
| Up-Regulation | 6 | 2008 | 4217 | 0.160 |
Why?
|
| Nonlinear Dynamics | 1 | 2021 | 502 | 0.160 |
Why?
|
| Myelin Proteolipid Protein | 5 | 2011 | 107 | 0.160 |
Why?
|
| STAT6 Transcription Factor | 4 | 2008 | 199 | 0.160 |
Why?
|
| Polysaccharides | 3 | 2015 | 1053 | 0.160 |
Why?
|
| Pregnancy, Multiple | 1 | 1999 | 217 | 0.160 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2016 | 1155 | 0.160 |
Why?
|
| Interferon Regulatory Factors | 2 | 2018 | 270 | 0.160 |
Why?
|
| Organometallic Compounds | 2 | 2019 | 665 | 0.160 |
Why?
|
| Cohort Studies | 11 | 2022 | 40561 | 0.160 |
Why?
|
| Histocompatibility Antigens Class II | 7 | 2001 | 1475 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell | 6 | 2016 | 2540 | 0.160 |
Why?
|
| Teratoma | 1 | 2001 | 395 | 0.160 |
Why?
|
| Urologic Diseases | 1 | 2000 | 244 | 0.160 |
Why?
|
| Verbal Learning | 1 | 2020 | 467 | 0.150 |
Why?
|
| Consensus | 4 | 2024 | 2959 | 0.150 |
Why?
|
| Mice, Inbred Strains | 5 | 2007 | 1827 | 0.150 |
Why?
|
| Contrast Media | 4 | 2019 | 5300 | 0.150 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2012 | 1836 | 0.150 |
Why?
|
| Hospitals, University | 1 | 2019 | 571 | 0.150 |
Why?
|
| Globus Pallidus | 1 | 2018 | 253 | 0.150 |
Why?
|
| Gene Expression | 5 | 2016 | 7799 | 0.150 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2012 | 880 | 0.150 |
Why?
|
| Interferons | 1 | 2021 | 706 | 0.150 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2001 | 340 | 0.150 |
Why?
|
| Clonal Anergy | 1 | 1998 | 169 | 0.150 |
Why?
|
| Tomography, Optical Coherence | 2 | 2022 | 2657 | 0.150 |
Why?
|
| Hydroxybutyrates | 1 | 2017 | 82 | 0.150 |
Why?
|
| Hypersensitivity, Delayed | 6 | 1997 | 484 | 0.150 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2011 | 712 | 0.150 |
Why?
|
| Sex Factors | 6 | 2022 | 10397 | 0.150 |
Why?
|
| Models, Psychological | 1 | 2021 | 811 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 3 | 2020 | 7279 | 0.150 |
Why?
|
| Risk Assessment | 1 | 2018 | 23338 | 0.140 |
Why?
|
| Neurodegenerative Diseases | 2 | 2008 | 1061 | 0.140 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 1998 | 180 | 0.140 |
Why?
|
| Anesthesia, Obstetrical | 1 | 1999 | 235 | 0.140 |
Why?
|
| Neural Pathways | 1 | 2007 | 2972 | 0.140 |
Why?
|
| Amino Acid Sequence | 9 | 2009 | 13815 | 0.140 |
Why?
|
| Molecular Sequence Data | 9 | 2009 | 18111 | 0.140 |
Why?
|
| Longitudinal Studies | 14 | 2018 | 13989 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2015 | 10943 | 0.140 |
Why?
|
| Physicians, Women | 1 | 2022 | 486 | 0.130 |
Why?
|
| Peptide Fragments | 9 | 2011 | 5097 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2010 | 644 | 0.130 |
Why?
|
| Meningoencephalitis | 1 | 2006 | 78 | 0.130 |
Why?
|
| JC Virus | 1 | 2015 | 85 | 0.130 |
Why?
|
| Receptors, OX40 | 2 | 2008 | 43 | 0.130 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2016 | 237 | 0.130 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 2455 | 0.130 |
Why?
|
| Models, Neurological | 3 | 2021 | 1774 | 0.130 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2016 | 378 | 0.130 |
Why?
|
| Immunity, Cellular | 5 | 2005 | 1607 | 0.130 |
Why?
|
| Histocompatibility Antigens | 5 | 2001 | 471 | 0.130 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 1996 | 124 | 0.130 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 1989 | 415 | 0.130 |
Why?
|
| Rats | 21 | 2006 | 24260 | 0.130 |
Why?
|
| Sleep Disorders, Intrinsic | 1 | 2014 | 15 | 0.120 |
Why?
|
| Time Factors | 14 | 2011 | 40075 | 0.120 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2003 | 1821 | 0.120 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2018 | 893 | 0.120 |
Why?
|
| Injections, Intralymphatic | 3 | 1999 | 15 | 0.120 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2016 | 443 | 0.120 |
Why?
|
| Testicular Neoplasms | 1 | 2001 | 804 | 0.120 |
Why?
|
| Cross-Sectional Studies | 8 | 2023 | 25043 | 0.120 |
Why?
|
| Voluntary Health Agencies | 1 | 1994 | 39 | 0.120 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1994 | 173 | 0.120 |
Why?
|
| Case-Control Studies | 6 | 2023 | 21746 | 0.120 |
Why?
|
| International Cooperation | 3 | 2010 | 1420 | 0.120 |
Why?
|
| Liver Function Tests | 1 | 2015 | 528 | 0.120 |
Why?
|
| Retinal Dehydrogenase | 1 | 2013 | 74 | 0.120 |
Why?
|
| Chronobiology Disorders | 1 | 2014 | 74 | 0.120 |
Why?
|
| Receptors, Calcitriol | 1 | 2016 | 350 | 0.110 |
Why?
|
| Autoantibodies | 4 | 2009 | 2035 | 0.110 |
Why?
|
| Polyomavirus Infections | 1 | 2015 | 197 | 0.110 |
Why?
|
| Program Evaluation | 2 | 2019 | 2488 | 0.110 |
Why?
|
| DNA-Binding Proteins | 4 | 2014 | 9648 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 2008 | 805 | 0.110 |
Why?
|
| Medicine | 1 | 2022 | 946 | 0.110 |
Why?
|
| Graft Rejection | 6 | 2009 | 4397 | 0.110 |
Why?
|
| Double-Blind Method | 6 | 2019 | 12026 | 0.110 |
Why?
|
| Immunoglobulin Fc Fragments | 2 | 2010 | 279 | 0.110 |
Why?
|
| Encephalitis | 1 | 2017 | 423 | 0.110 |
Why?
|
| Cell Division | 6 | 2004 | 4568 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1434 | 0.110 |
Why?
|
| Prostaglandins E | 1 | 1992 | 172 | 0.110 |
Why?
|
| STAT5 Transcription Factor | 2 | 2014 | 259 | 0.110 |
Why?
|
| Statistics as Topic | 3 | 2016 | 2373 | 0.110 |
Why?
|
| Neoplasms, Second Primary | 1 | 2001 | 1061 | 0.110 |
Why?
|
| Major Histocompatibility Complex | 3 | 2002 | 936 | 0.110 |
Why?
|
| Methylprednisolone | 3 | 1999 | 387 | 0.110 |
Why?
|
| Receptors, Interleukin-9 | 1 | 2012 | 4 | 0.110 |
Why?
|
| Tumor Virus Infections | 1 | 2015 | 452 | 0.110 |
Why?
|
| Astrocytes | 3 | 2012 | 1270 | 0.110 |
Why?
|
| Immunomodulation | 1 | 2016 | 541 | 0.110 |
Why?
|
| Treatment Outcome | 7 | 2022 | 63114 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2013 | 264 | 0.110 |
Why?
|
| Brain Neoplasms | 2 | 2012 | 8863 | 0.110 |
Why?
|
| Prostatic Neoplasms | 7 | 1996 | 11124 | 0.110 |
Why?
|
| HLA-B Antigens | 2 | 2010 | 353 | 0.100 |
Why?
|
| Nitriles | 1 | 2017 | 956 | 0.100 |
Why?
|
| Amino Sugars | 1 | 2011 | 40 | 0.100 |
Why?
|
| HLA-DR Antigens | 2 | 2010 | 645 | 0.100 |
Why?
|
| Quality of Life | 4 | 2023 | 12804 | 0.100 |
Why?
|
| Prospective Studies | 15 | 2022 | 53288 | 0.100 |
Why?
|
| Amyloid beta-Peptides | 2 | 2006 | 3587 | 0.100 |
Why?
|
| Age Factors | 8 | 2017 | 18370 | 0.100 |
Why?
|
| HEK293 Cells | 2 | 2019 | 4204 | 0.100 |
Why?
|
| Down-Regulation | 3 | 2007 | 3002 | 0.100 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 713 | 0.100 |
Why?
|
| Lipopolysaccharides | 3 | 2001 | 2216 | 0.100 |
Why?
|
| Blotting, Western | 2 | 2011 | 5179 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 1526 | 0.100 |
Why?
|
| Galectin 1 | 1 | 2012 | 131 | 0.100 |
Why?
|
| RNA | 2 | 2012 | 2749 | 0.100 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 7722 | 0.100 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 38 | 0.100 |
Why?
|
| Immune System | 2 | 2008 | 805 | 0.100 |
Why?
|
| Alzheimer Disease | 4 | 2019 | 8037 | 0.100 |
Why?
|
| Psychometrics | 1 | 2020 | 3002 | 0.100 |
Why?
|
| Gene Expression Regulation | 7 | 2018 | 12072 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2001 | 2942 | 0.090 |
Why?
|
| Retrospective Studies | 18 | 2024 | 77449 | 0.090 |
Why?
|
| Thymectomy | 3 | 1997 | 191 | 0.090 |
Why?
|
| Immunophenotyping | 5 | 2008 | 1880 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2016 | 17446 | 0.090 |
Why?
|
| Drug Therapy, Combination | 7 | 2010 | 6489 | 0.090 |
Why?
|
| Isoantigens | 3 | 2001 | 567 | 0.090 |
Why?
|
| Bayes Theorem | 1 | 2018 | 2309 | 0.090 |
Why?
|
| Immunization | 5 | 2016 | 1256 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2013 | 1682 | 0.090 |
Why?
|
| Age of Onset | 5 | 2023 | 3271 | 0.090 |
Why?
|
| Minocycline | 1 | 2011 | 163 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2019 | 1414 | 0.090 |
Why?
|
| Muromonab-CD3 | 1 | 2009 | 96 | 0.090 |
Why?
|
| Immunotherapy | 5 | 2012 | 4445 | 0.090 |
Why?
|
| Interviews as Topic | 1 | 2016 | 2539 | 0.090 |
Why?
|
| Prostatism | 1 | 2009 | 14 | 0.090 |
Why?
|
| Drug Administration Schedule | 3 | 2010 | 4933 | 0.090 |
Why?
|
| Subarachnoid Space | 1 | 2009 | 79 | 0.080 |
Why?
|
| Phenotype | 5 | 2017 | 16365 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2009 | 675 | 0.080 |
Why?
|
| Bruxism | 1 | 2008 | 15 | 0.080 |
Why?
|
| Brain Chemistry | 1 | 1992 | 981 | 0.080 |
Why?
|
| Carotid Artery Thrombosis | 1 | 1988 | 53 | 0.080 |
Why?
|
| Masticatory Muscles | 1 | 2008 | 29 | 0.080 |
Why?
|
| Blood Pressure Determination | 1 | 1992 | 634 | 0.080 |
Why?
|
| Kuwait | 2 | 2019 | 86 | 0.080 |
Why?
|
| Stomach Neoplasms | 1 | 1998 | 1333 | 0.080 |
Why?
|
| Immunohistochemistry | 6 | 2010 | 11366 | 0.080 |
Why?
|
| Ligands | 3 | 2007 | 3282 | 0.080 |
Why?
|
| Referral and Consultation | 2 | 2017 | 3528 | 0.080 |
Why?
|
| Interleukin-13 | 1 | 2010 | 389 | 0.080 |
Why?
|
| HLA Antigens | 2 | 2010 | 1381 | 0.080 |
Why?
|
| Gene Expression Profiling | 4 | 2012 | 9438 | 0.080 |
Why?
|
| Receptors, Notch | 2 | 2015 | 739 | 0.080 |
Why?
|
| Chronic Disease | 5 | 2010 | 9146 | 0.080 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 19905 | 0.080 |
Why?
|
| src Homology Domains | 1 | 2008 | 364 | 0.080 |
Why?
|
| Femoral Artery | 2 | 2008 | 845 | 0.080 |
Why?
|
| Blood-Brain Barrier | 2 | 2012 | 1017 | 0.080 |
Why?
|
| Subtraction Technique | 1 | 2011 | 525 | 0.080 |
Why?
|
| Interleukin-23 | 1 | 2009 | 193 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1783 | 0.080 |
Why?
|
| Africa, Northern | 2 | 2019 | 82 | 0.080 |
Why?
|
| Endarterectomy | 1 | 1988 | 195 | 0.080 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2010 | 135 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2016 | 6365 | 0.080 |
Why?
|
| Chemokine CXCL10 | 2 | 2013 | 304 | 0.080 |
Why?
|
| Nitric Oxide | 2 | 2011 | 2132 | 0.070 |
Why?
|
| Receptors, CXCR3 | 1 | 2008 | 237 | 0.070 |
Why?
|
| Embryo, Mammalian | 3 | 2008 | 1701 | 0.070 |
Why?
|
| Femoral Vein | 1 | 2008 | 159 | 0.070 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 2008 | 906 | 0.070 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2016 | 1008 | 0.070 |
Why?
|
| Epilepsy | 1 | 2023 | 3310 | 0.070 |
Why?
|
| Fecal Incontinence | 1 | 2010 | 239 | 0.070 |
Why?
|
| Myelin Sheath | 4 | 2009 | 652 | 0.070 |
Why?
|
| Medulla Oblongata | 1 | 2008 | 243 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2016 | 2969 | 0.070 |
Why?
|
| Cell Count | 1 | 2011 | 1856 | 0.070 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2008 | 227 | 0.070 |
Why?
|
| B-Lymphocytes | 3 | 2009 | 4665 | 0.070 |
Why?
|
| Prognosis | 10 | 2023 | 29063 | 0.070 |
Why?
|
| Societies, Medical | 2 | 2000 | 3743 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 12245 | 0.070 |
Why?
|
| Parkinson Disease | 2 | 2019 | 2775 | 0.070 |
Why?
|
| Cell Line | 7 | 2004 | 15997 | 0.070 |
Why?
|
| Immunity, Innate | 3 | 2011 | 2958 | 0.070 |
Why?
|
| Disease Susceptibility | 2 | 2006 | 1782 | 0.070 |
Why?
|
| Algorithms | 3 | 2023 | 13881 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2011 | 4042 | 0.070 |
Why?
|
| Fetal Resorption | 1 | 2005 | 17 | 0.070 |
Why?
|
| Kinetics | 3 | 1998 | 6473 | 0.070 |
Why?
|
| Receptor, Bradykinin B1 | 1 | 2005 | 10 | 0.070 |
Why?
|
| Glycoproteins | 3 | 2009 | 2263 | 0.070 |
Why?
|
| Follow-Up Studies | 8 | 2018 | 39050 | 0.070 |
Why?
|
| Microarray Analysis | 1 | 2008 | 767 | 0.070 |
Why?
|
| Leptin | 1 | 2013 | 1599 | 0.070 |
Why?
|
| Chemokine CCL2 | 2 | 2012 | 617 | 0.070 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2005 | 192 | 0.060 |
Why?
|
| Urinary Incontinence | 1 | 2010 | 496 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5442 | 0.060 |
Why?
|
| Aged | 17 | 2018 | 163280 | 0.060 |
Why?
|
| Protein Binding | 5 | 2016 | 9386 | 0.060 |
Why?
|
| Pilot Projects | 4 | 2020 | 8324 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 2861 | 0.060 |
Why?
|
| Gadolinium DTPA | 2 | 2019 | 836 | 0.060 |
Why?
|
| Adolescent | 16 | 2018 | 85781 | 0.060 |
Why?
|
| Hematopoietic System | 1 | 2005 | 109 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2012 | 3772 | 0.060 |
Why?
|
| Janus Kinase 1 | 1 | 2005 | 104 | 0.060 |
Why?
|
| STAT4 Transcription Factor | 2 | 2001 | 96 | 0.060 |
Why?
|
| Urology | 1 | 2010 | 399 | 0.060 |
Why?
|
| Receptors, Interleukin-2 | 3 | 2005 | 573 | 0.060 |
Why?
|
| Cell Communication | 1 | 2012 | 1621 | 0.060 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2008 | 277 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 905 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2019 | 3265 | 0.060 |
Why?
|
| I-kappa B Proteins | 1 | 2005 | 225 | 0.060 |
Why?
|
| Environmental Exposure | 1 | 2019 | 4234 | 0.060 |
Why?
|
| Antibody Formation | 3 | 2003 | 1402 | 0.060 |
Why?
|
| Secondary Prevention | 1 | 2011 | 1530 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 3920 | 0.060 |
Why?
|
| Hepatitis C Antibodies | 2 | 2001 | 145 | 0.060 |
Why?
|
| Macrophage Activation | 1 | 2007 | 558 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2013 | 4420 | 0.060 |
Why?
|
| Blood Flow Velocity | 1 | 2008 | 1423 | 0.060 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 2 | 2016 | 140 | 0.060 |
Why?
|
| Sex Characteristics | 2 | 2013 | 2585 | 0.060 |
Why?
|
| Physicians | 1 | 2022 | 4567 | 0.060 |
Why?
|
| Antibodies, Viral | 1 | 2015 | 3176 | 0.060 |
Why?
|
| Carotid Arteries | 1 | 1988 | 952 | 0.060 |
Why?
|
| Gastroenterology | 1 | 2010 | 536 | 0.060 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2003 | 133 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2017 | 7729 | 0.060 |
Why?
|
| Glucocorticoids | 2 | 2005 | 2107 | 0.060 |
Why?
|
| Brain Stem | 1 | 2008 | 846 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2001 | 6364 | 0.060 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2005 | 456 | 0.060 |
Why?
|
| Students, Medical | 1 | 2016 | 1862 | 0.060 |
Why?
|
| Cladribine | 1 | 2022 | 34 | 0.060 |
Why?
|
| Galectins | 1 | 2005 | 268 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 2088 | 0.050 |
Why?
|
| Lymphocyte Count | 1 | 2005 | 793 | 0.050 |
Why?
|
| Chemokine CCL7 | 1 | 2002 | 27 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 2505 | 0.050 |
Why?
|
| NAD | 1 | 2006 | 593 | 0.050 |
Why?
|
| Biomedical Research | 2 | 2016 | 3309 | 0.050 |
Why?
|
| Homeodomain Proteins | 3 | 2012 | 2421 | 0.050 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2009 | 1366 | 0.050 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2002 | 48 | 0.050 |
Why?
|
| Cost of Illness | 2 | 2023 | 1859 | 0.050 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2004 | 599 | 0.050 |
Why?
|
| Interleukins | 1 | 2007 | 791 | 0.050 |
Why?
|
| Brain Injuries | 1 | 2014 | 2025 | 0.050 |
Why?
|
| Hydroxamic Acids | 1 | 2005 | 494 | 0.050 |
Why?
|
| Antibody Affinity | 1 | 2003 | 254 | 0.050 |
Why?
|
| Chemokine CXCL9 | 1 | 2002 | 132 | 0.050 |
Why?
|
| Registries | 3 | 2024 | 8089 | 0.050 |
Why?
|
| Receptors, Virus | 1 | 2005 | 648 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 3 | 2015 | 401 | 0.050 |
Why?
|
| Cerebral Ventricles | 1 | 2004 | 544 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
| Reference Values | 4 | 2020 | 4982 | 0.050 |
Why?
|
| Phagocytosis | 1 | 2007 | 1539 | 0.050 |
Why?
|
| Bucladesine | 1 | 2001 | 121 | 0.050 |
Why?
|
| Interleukin-6 | 2 | 2012 | 3200 | 0.050 |
Why?
|
| Droperidol | 1 | 2001 | 21 | 0.050 |
Why?
|
| Seasons | 2 | 1998 | 1493 | 0.050 |
Why?
|
| Abdominal Injuries | 2 | 1996 | 352 | 0.050 |
Why?
|
| Metoclopramide | 1 | 2001 | 51 | 0.050 |
Why?
|
| Wounds, Penetrating | 2 | 1996 | 307 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 1992 | 2708 | 0.050 |
Why?
|
| OX40 Ligand | 1 | 2001 | 51 | 0.050 |
Why?
|
| Tumor Necrosis Factors | 1 | 2001 | 109 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2003 | 1157 | 0.050 |
Why?
|
| Image Enhancement | 1 | 2012 | 2921 | 0.050 |
Why?
|
| Logistic Models | 3 | 2010 | 13408 | 0.050 |
Why?
|
| Rats, Inbred WF | 5 | 2001 | 140 | 0.050 |
Why?
|
| Models, Statistical | 3 | 2022 | 5102 | 0.050 |
Why?
|
| Topography, Medical | 2 | 2001 | 37 | 0.050 |
Why?
|
| Transplantation Immunology | 2 | 2001 | 546 | 0.050 |
Why?
|
| Skin Physiological Phenomena | 1 | 2001 | 180 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 2916 | 0.050 |
Why?
|
| Interleukin-18 | 1 | 2002 | 249 | 0.050 |
Why?
|
| Clone Cells | 5 | 2008 | 1692 | 0.050 |
Why?
|
| Hepatitis C | 2 | 2001 | 1591 | 0.050 |
Why?
|
| Ondansetron | 1 | 2001 | 90 | 0.050 |
Why?
|
| Chemokines, CXC | 1 | 2002 | 422 | 0.050 |
Why?
|
| Lymph Nodes | 6 | 2016 | 3474 | 0.050 |
Why?
|
| Child | 10 | 2024 | 77709 | 0.050 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2000 | 91 | 0.050 |
Why?
|
| Occupational Diseases | 2 | 2001 | 1471 | 0.050 |
Why?
|
| Iron | 1 | 2009 | 1774 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2010 | 2866 | 0.050 |
Why?
|
| Australia | 1 | 2023 | 1170 | 0.050 |
Why?
|
| Spinal Cord Injuries | 1 | 2008 | 931 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2015 | 3712 | 0.040 |
Why?
|
| Neoplasm Staging | 3 | 1996 | 11031 | 0.040 |
Why?
|
| Glioma | 2 | 2012 | 3401 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2003 | 581 | 0.040 |
Why?
|
| Anesthesia, Inhalation | 1 | 2000 | 223 | 0.040 |
Why?
|
| Neuroprotective Agents | 1 | 2006 | 941 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 3703 | 0.040 |
Why?
|
| Career Mobility | 1 | 2022 | 262 | 0.040 |
Why?
|
| Cycloheximide | 1 | 1999 | 347 | 0.040 |
Why?
|
| Desensitization, Immunologic | 2 | 1995 | 483 | 0.040 |
Why?
|
| Antiemetics | 1 | 2001 | 177 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2019 | 6600 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2019 | 5788 | 0.040 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 1996 | 97 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2002 | 690 | 0.040 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.040 |
Why?
|
| Asthma | 1 | 2018 | 6011 | 0.040 |
Why?
|
| Drug Resistance | 4 | 2010 | 1609 | 0.040 |
Why?
|
| Kidney Transplantation | 3 | 2004 | 4251 | 0.040 |
Why?
|
| Health Care Costs | 2 | 2023 | 3209 | 0.040 |
Why?
|
| Epitopes | 2 | 1997 | 2571 | 0.040 |
Why?
|
| Blood Donors | 1 | 2001 | 355 | 0.040 |
Why?
|
| Personnel, Hospital | 1 | 2001 | 283 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2023 | 1060 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 15519 | 0.040 |
Why?
|
| Genes, MHC Class II | 2 | 2005 | 457 | 0.040 |
Why?
|
| bcl-X Protein | 1 | 2000 | 411 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 1677 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2008 | 1786 | 0.040 |
Why?
|
| Antibodies, Blocking | 1 | 1999 | 253 | 0.040 |
Why?
|
| Withholding Treatment | 1 | 2022 | 599 | 0.040 |
Why?
|
| Nausea | 1 | 2001 | 673 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2000 | 925 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2001 | 880 | 0.040 |
Why?
|
| Antigens, CD20 | 1 | 2018 | 199 | 0.040 |
Why?
|
| Muramidase | 1 | 1998 | 174 | 0.040 |
Why?
|
| Pregnancy | 5 | 2024 | 29144 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2010 | 9849 | 0.040 |
Why?
|
| Species Specificity | 1 | 2002 | 2478 | 0.040 |
Why?
|
| Risk Factors | 5 | 2023 | 72290 | 0.040 |
Why?
|
| Neurology | 1 | 2006 | 763 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 2699 | 0.040 |
Why?
|
| Veins | 1 | 2021 | 770 | 0.040 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2018 | 134 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2013 | 3752 | 0.040 |
Why?
|
| Alkylating Agents | 1 | 1997 | 139 | 0.040 |
Why?
|
| Off-Label Use | 1 | 2018 | 169 | 0.040 |
Why?
|
| Chemokines | 2 | 2016 | 970 | 0.040 |
Why?
|
| Immunodominant Epitopes | 1 | 1998 | 267 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 1998 | 573 | 0.040 |
Why?
|
| Receptors, Interleukin | 2 | 2012 | 245 | 0.040 |
Why?
|
| Leg Dermatoses | 1 | 1996 | 20 | 0.040 |
Why?
|
| Blood Pressure | 1 | 1992 | 8554 | 0.040 |
Why?
|
| Integrin alpha4beta1 | 1 | 2016 | 121 | 0.040 |
Why?
|
| Gastroscopy | 1 | 1998 | 207 | 0.040 |
Why?
|
| Jordan | 1 | 1996 | 74 | 0.040 |
Why?
|
| Clinical Trials as Topic | 4 | 2003 | 7913 | 0.030 |
Why?
|
| Military Personnel | 2 | 2014 | 1133 | 0.030 |
Why?
|
| Sensitivity and Specificity | 5 | 2011 | 14722 | 0.030 |
Why?
|
| Immunogenetics | 1 | 2006 | 67 | 0.030 |
Why?
|
| Adenoviruses, Human | 1 | 1998 | 257 | 0.030 |
Why?
|
| Iliac Vein | 1 | 1996 | 72 | 0.030 |
Why?
|
| Facial Dermatoses | 1 | 1996 | 87 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 2 | 2006 | 126 | 0.030 |
Why?
|
| Lymphocyte Transfusion | 1 | 1997 | 236 | 0.030 |
Why?
|
| Neoplasm Metastasis | 3 | 1996 | 4851 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2023 | 9239 | 0.030 |
Why?
|
| Mutation | 3 | 2023 | 29786 | 0.030 |
Why?
|
| Ischemia | 1 | 2004 | 1907 | 0.030 |
Why?
|
| Career Choice | 1 | 2022 | 744 | 0.030 |
Why?
|
| Urinary Bladder | 1 | 2022 | 1172 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2004 | 1422 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 5867 | 0.030 |
Why?
|
| Selectins | 1 | 2015 | 102 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2022 | 880 | 0.030 |
Why?
|
| Zoonoses | 1 | 1996 | 185 | 0.030 |
Why?
|
| Cyclosporine | 1 | 1998 | 786 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2000 | 721 | 0.030 |
Why?
|
| Rats, Inbred BN | 4 | 1997 | 235 | 0.030 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2015 | 126 | 0.030 |
Why?
|
| Agriculture | 1 | 1996 | 190 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 8949 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2010 | 3336 | 0.030 |
Why?
|
| Rodentia | 1 | 1996 | 261 | 0.030 |
Why?
|
| Drug Synergism | 1 | 1999 | 1792 | 0.030 |
Why?
|
| Achievement | 1 | 2016 | 291 | 0.030 |
Why?
|
| Iliac Artery | 1 | 1996 | 364 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2886 | 0.030 |
Why?
|
| Aging | 1 | 2013 | 8664 | 0.030 |
Why?
|
| Janus Kinase 3 | 1 | 2014 | 78 | 0.030 |
Why?
|
| Prevalence | 3 | 2015 | 15226 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2016 | 707 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2003 | 1888 | 0.030 |
Why?
|
| Phorbol Esters | 1 | 2013 | 111 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2005 | 8436 | 0.030 |
Why?
|
| Melanoma | 1 | 2012 | 5510 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 193 | 0.030 |
Why?
|
| Interferon-alpha | 1 | 1998 | 895 | 0.030 |
Why?
|
| Brain Damage, Chronic | 1 | 2014 | 265 | 0.030 |
Why?
|
| Stomach | 1 | 1998 | 697 | 0.030 |
Why?
|
| Problem Solving | 1 | 2016 | 440 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2010 | 3588 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 1998 | 1100 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2004 | 3023 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2007 | 6622 | 0.030 |
Why?
|
| Wounds, Gunshot | 3 | 1996 | 563 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 3462 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 3617 | 0.030 |
Why?
|
| Arm | 1 | 1996 | 589 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 1996 | 646 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2010 | 3508 | 0.030 |
Why?
|
| Homeostasis | 1 | 2004 | 3340 | 0.030 |
Why?
|
| Age Distribution | 2 | 2009 | 2902 | 0.030 |
Why?
|
| Vena Cava, Inferior | 1 | 1996 | 440 | 0.030 |
Why?
|
| Immunization, Passive | 1 | 1995 | 623 | 0.030 |
Why?
|
| Uveitis | 3 | 1994 | 375 | 0.030 |
Why?
|
| Genotype | 3 | 2013 | 12951 | 0.030 |
Why?
|
| Myelitis | 1 | 2013 | 53 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2012 | 5686 | 0.030 |
Why?
|
| Skin Diseases | 1 | 2001 | 1065 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 7181 | 0.030 |
Why?
|
| Treatment Failure | 3 | 2009 | 2618 | 0.030 |
Why?
|
| Radiation Chimera | 1 | 2012 | 223 | 0.030 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1992 | 174 | 0.030 |
Why?
|
| Coculture Techniques | 2 | 2010 | 1341 | 0.030 |
Why?
|
| Thalamus | 1 | 2018 | 1023 | 0.030 |
Why?
|
| Lymphocyte Culture Test, Mixed | 3 | 2001 | 517 | 0.030 |
Why?
|
| Endocrine System Diseases | 1 | 2014 | 248 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2018 | 3327 | 0.030 |
Why?
|
| Terminology as Topic | 2 | 2010 | 1547 | 0.030 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2012 | 114 | 0.030 |
Why?
|
| Haplorhini | 1 | 1992 | 552 | 0.030 |
Why?
|
| Predictive Value of Tests | 4 | 2009 | 15076 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 1993 | 1386 | 0.020 |
Why?
|
| Endothelium | 1 | 1994 | 778 | 0.020 |
Why?
|
| Nitrosourea Compounds | 1 | 1991 | 32 | 0.020 |
Why?
|
| Foreign-Body Migration | 1 | 1993 | 222 | 0.020 |
Why?
|
| Optic Neuritis | 1 | 2013 | 166 | 0.020 |
Why?
|
| Lipid A | 1 | 1990 | 67 | 0.020 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2014 | 271 | 0.020 |
Why?
|
| Rural Health | 1 | 1992 | 305 | 0.020 |
Why?
|
| DNA Primers | 1 | 1995 | 2892 | 0.020 |
Why?
|
| Incidence | 3 | 2013 | 20947 | 0.020 |
Why?
|
| Blast Injuries | 1 | 2014 | 302 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 534 | 0.020 |
Why?
|
| Vaccination | 2 | 2012 | 3278 | 0.020 |
Why?
|
| Glutamine | 1 | 2013 | 578 | 0.020 |
Why?
|
| HLA-C Antigens | 1 | 2010 | 147 | 0.020 |
Why?
|
| Carotid Artery Injuries | 1 | 1990 | 96 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2017 | 1257 | 0.020 |
Why?
|
| Spinal Cord Diseases | 1 | 2013 | 298 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1996 | 1462 | 0.020 |
Why?
|
| HLA-A Antigens | 1 | 2010 | 231 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 528 | 0.020 |
Why?
|
| DNA | 1 | 2004 | 7301 | 0.020 |
Why?
|
| Caregivers | 1 | 2021 | 2094 | 0.020 |
Why?
|
| Embolism | 1 | 1993 | 408 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2016 | 3144 | 0.020 |
Why?
|
| Arginine | 1 | 2013 | 944 | 0.020 |
Why?
|
| Glucosylceramides | 1 | 2009 | 28 | 0.020 |
Why?
|
| Organophosphorus Compounds | 1 | 1991 | 215 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2012 | 514 | 0.020 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2009 | 50 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 1998 | 1901 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 5853 | 0.020 |
Why?
|
| Base Sequence | 2 | 2005 | 12797 | 0.020 |
Why?
|
| Supratentorial Neoplasms | 1 | 1991 | 160 | 0.020 |
Why?
|
| Alleles | 2 | 2010 | 6933 | 0.020 |
Why?
|
| Optic Nerve Diseases | 1 | 2013 | 327 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2009 | 370 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 697 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2016 | 1210 | 0.020 |
Why?
|
| Hyperthermia, Induced | 1 | 1992 | 403 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2012 | 1005 | 0.020 |
Why?
|
| Melanoma, Experimental | 1 | 2012 | 561 | 0.020 |
Why?
|
| Organizations | 1 | 2010 | 170 | 0.020 |
Why?
|
| Oxygen | 1 | 2000 | 4189 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2001 | 2151 | 0.020 |
Why?
|
| Dental Occlusion | 1 | 2008 | 54 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2016 | 1425 | 0.020 |
Why?
|
| Melatonin | 1 | 2014 | 721 | 0.020 |
Why?
|
| Hormones | 1 | 1992 | 889 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2023 | 12354 | 0.020 |
Why?
|
| Cell Cycle | 2 | 2008 | 2967 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 1998 | 3420 | 0.020 |
Why?
|
| Graft Survival | 1 | 1999 | 3737 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 1 | 2008 | 157 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2012 | 652 | 0.020 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2014 | 794 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1997 | 1790 | 0.020 |
Why?
|
| Dogs | 1 | 1992 | 3912 | 0.020 |
Why?
|
| Encephalomyelitis | 1 | 2007 | 34 | 0.020 |
Why?
|
| Demography | 1 | 2012 | 1656 | 0.020 |
Why?
|
| Serum | 1 | 2008 | 214 | 0.020 |
Why?
|
| Brain Infarction | 1 | 2009 | 299 | 0.020 |
Why?
|
| Decision Trees | 1 | 2009 | 506 | 0.020 |
Why?
|
| Arthritis, Experimental | 3 | 1995 | 291 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 2759 | 0.020 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 1987 | 81 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2010 | 645 | 0.020 |
Why?
|
| Risk | 1 | 2019 | 9687 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2011 | 2031 | 0.020 |
Why?
|
| Wallerian Degeneration | 1 | 2006 | 69 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2012 | 1038 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2012 | 1915 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2014 | 1162 | 0.020 |
Why?
|
| Biopsy | 1 | 1998 | 6756 | 0.020 |
Why?
|
| Complementarity Determining Regions | 1 | 2006 | 149 | 0.020 |
Why?
|
| Tetrazolium Salts | 1 | 2005 | 96 | 0.020 |
Why?
|
| Immunologic Tests | 1 | 2006 | 103 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2005 | 13033 | 0.020 |
Why?
|
| Laser Therapy | 1 | 1992 | 1072 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2008 | 458 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 2715 | 0.020 |
Why?
|
| Transplantation, Homologous | 3 | 2000 | 4776 | 0.020 |
Why?
|
| Mental Health | 1 | 2019 | 3019 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2008 | 2645 | 0.020 |
Why?
|
| Mast Cells | 1 | 2012 | 1544 | 0.020 |
Why?
|
| Frail Elderly | 1 | 2010 | 693 | 0.020 |
Why?
|
| Cancer Vaccines | 1 | 2012 | 1023 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2009 | 1654 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 2924 | 0.020 |
Why?
|
| Monitoring, Immunologic | 1 | 2004 | 100 | 0.020 |
Why?
|
| Peyer's Patches | 2 | 1995 | 121 | 0.010 |
Why?
|
| Fluorouracil | 2 | 1979 | 1619 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2019 | 4687 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 2007 | 930 | 0.010 |
Why?
|
| Schools | 1 | 1992 | 1433 | 0.010 |
Why?
|
| Endosonography | 1 | 2008 | 610 | 0.010 |
Why?
|
| Markov Chains | 1 | 2007 | 969 | 0.010 |
Why?
|
| Intestine, Small | 1 | 1990 | 1241 | 0.010 |
Why?
|
| Prostatectomy | 1 | 1992 | 1890 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2004 | 642 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2012 | 2499 | 0.010 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2012 | 1270 | 0.010 |
Why?
|
| Hippocampus | 1 | 2006 | 3675 | 0.010 |
Why?
|
| Forecasting | 1 | 1992 | 2951 | 0.010 |
Why?
|
| Electromyography | 1 | 2008 | 1379 | 0.010 |
Why?
|
| Radiography | 2 | 2010 | 7023 | 0.010 |
Why?
|
| Linear Models | 1 | 2013 | 5952 | 0.010 |
Why?
|
| Child, Preschool | 3 | 2009 | 41006 | 0.010 |
Why?
|
| Organogenesis | 1 | 2004 | 222 | 0.010 |
Why?
|
| Inpatients | 1 | 2014 | 2518 | 0.010 |
Why?
|
| Receptors, Interleukin-18 | 1 | 2002 | 22 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2006 | 1588 | 0.010 |
Why?
|
| Interleukin-18 Receptor alpha Subunit | 1 | 2002 | 18 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2003 | 919 | 0.010 |
Why?
|
| Arousal | 1 | 2008 | 1165 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 3843 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 12959 | 0.010 |
Why?
|
| Angiography | 1 | 2008 | 1639 | 0.010 |
Why?
|
| Models, Animal | 1 | 2008 | 2171 | 0.010 |
Why?
|
| Polysomnography | 1 | 2008 | 1776 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2011 | 5078 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2005 | 8301 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2008 | 2751 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 1992 | 2624 | 0.010 |
Why?
|
| Stents | 1 | 1992 | 3280 | 0.010 |
Why?
|
| Depression | 1 | 2020 | 7766 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2005 | 1460 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2010 | 3494 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2003 | 708 | 0.010 |
Why?
|
| Cattle | 2 | 1996 | 3922 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
| Cell Death | 1 | 2005 | 1706 | 0.010 |
Why?
|
| Cholesterol | 1 | 2008 | 2917 | 0.010 |
Why?
|
| Transfection | 1 | 2007 | 5892 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2004 | 2726 | 0.010 |
Why?
|
| Antibodies | 1 | 2007 | 2460 | 0.010 |
Why?
|
| Skin | 1 | 2012 | 4364 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 2003 | 1878 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6538 | 0.010 |
Why?
|
| Thiazoles | 1 | 2005 | 1483 | 0.010 |
Why?
|
| Tetanus Toxoid | 1 | 1998 | 193 | 0.010 |
Why?
|
| Organ Specificity | 2 | 1994 | 2008 | 0.010 |
Why?
|
| Vomiting | 1 | 2001 | 636 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 3610 | 0.010 |
Why?
|
| Swine | 1 | 2008 | 5917 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2001 | 1799 | 0.010 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2008 | 1632 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2005 | 4011 | 0.010 |
Why?
|
| Bone Neoplasms | 2 | 1979 | 2529 | 0.010 |
Why?
|
| Pancreas | 1 | 2003 | 1686 | 0.010 |
Why?
|
| Apoproteins | 1 | 1996 | 44 | 0.010 |
Why?
|
| Tamoxifen | 1 | 2001 | 981 | 0.010 |
Why?
|
| Primary Health Care | 1 | 1992 | 4558 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2005 | 2504 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1997 | 1420 | 0.010 |
Why?
|
| Hospitalization | 1 | 2014 | 10262 | 0.010 |
Why?
|
| Estrogens | 2 | 1979 | 1566 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1996 | 2186 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2008 | 6196 | 0.010 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 1994 | 42 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2004 | 3760 | 0.010 |
Why?
|
| Models, Biological | 2 | 2005 | 9583 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1997 | 640 | 0.010 |
Why?
|
| HLA-DR2 Antigen | 1 | 1993 | 48 | 0.010 |
Why?
|
| Wound Healing | 1 | 2004 | 2785 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2008 | 4245 | 0.010 |
Why?
|
| Sleep | 1 | 2008 | 4623 | 0.010 |
Why?
|
| Hypertension | 1 | 1992 | 8480 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2005 | 3386 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1994 | 455 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1995 | 903 | 0.010 |
Why?
|
| Immunity, Mucosal | 1 | 1995 | 490 | 0.010 |
Why?
|
| Heart Injuries | 1 | 1993 | 210 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 12261 | 0.010 |
Why?
|
| Injections | 1 | 1994 | 840 | 0.010 |
Why?
|
| Methotrexate | 1 | 1997 | 1727 | 0.010 |
Why?
|
| Occupational Exposure | 1 | 2001 | 1796 | 0.010 |
Why?
|
| Indomethacin | 1 | 1990 | 332 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1991 | 647 | 0.010 |
Why?
|
| Neck Injuries | 1 | 1990 | 152 | 0.010 |
Why?
|
| Prostaglandins | 1 | 1990 | 405 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2001 | 3396 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1991 | 13695 | 0.000 |
Why?
|
| Acute Disease | 1 | 1998 | 7149 | 0.000 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1997 | 6038 | 0.000 |
Why?
|
| Heart Transplantation | 1 | 2000 | 3110 | 0.000 |
Why?
|
| Surgical Wound Infection | 1 | 1996 | 1540 | 0.000 |
Why?
|
| Calcium | 1 | 2000 | 5756 | 0.000 |
Why?
|
| Haplotypes | 1 | 1993 | 2779 | 0.000 |
Why?
|
| Interleukin-1 | 1 | 1990 | 1263 | 0.000 |
Why?
|
| Cause of Death | 1 | 1996 | 3584 | 0.000 |
Why?
|
| Epithelium | 1 | 1990 | 1679 | 0.000 |
Why?
|
| Vaccines | 1 | 1994 | 822 | 0.000 |
Why?
|
| Hypersensitivity | 1 | 1994 | 1102 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 20129 | 0.000 |
Why?
|
| Intestines | 1 | 1994 | 1924 | 0.000 |
Why?
|
| Emergencies | 1 | 1990 | 1170 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1994 | 3036 | 0.000 |
Why?
|
| Polymorphism, Genetic | 1 | 1993 | 4328 | 0.000 |
Why?
|
| Survival Rate | 1 | 1996 | 12788 | 0.000 |
Why?
|
| Heart Ventricles | 1 | 1993 | 3821 | 0.000 |
Why?
|
| Research Design | 1 | 1996 | 5987 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2001 | 15295 | 0.000 |
Why?
|
| Epithelial Cells | 1 | 1990 | 3690 | 0.000 |
Why?
|
| Palliative Care | 2 | 1979 | 3493 | 0.000 |
Why?
|